Biotech company LifeMine Therapeutics has raised $263 million to support [...]

Kupando has dosed the first patient in a Phase 1 [...]

Adneuris Therapeutics has granted Maruishi Pharmaceutical exclusive rights to develop [...]

An AI-driven virtual screening platform developed by Deep Origin has [...]

Obsidian Therapeutics has enrolled the first patient in the registration-enabling [...]

New England Biolabs has launched a magnetic bead-based extraction kit [...]

Norstella has launched an agentic AI platform designed to combine [...]

QuantHealth has raised $45 million in a Series B funding [...]

Circio is preparing to advance its circular RNA gene therapy [...]

Vaximm AG has completed analysis of two clinical studies evaluating [...]